Celluma devices are: FDA-cleared for multiple indications Clinically studied for skin, acne, and pain Designed to deliver consistent, therapeutic light wavelengths Trusted by medical and aesthetic professionals worldwide Using Celluma allows us to confidently integrate LED therapy into treatment plans knowing patients are receiving care backed by sciencenot just trends
Perform baseline investigations , including fasting glucose, HbA1c, lipid profile, renal and liver function tests, full blood count, and thyroid function
As of mid-2025, the FDA documented 605 adverse event reports specifically related to compounded semaglutide
This research is supported by grants from the National Science and Technology Council, Taiwan (NSTC 112-2326-B-002-006 and NSTC 1122320-B-002-005)
There were no serious drug-related adverse events in SKYLIGHT 2, and only two (increased transaminases and abnormal liver function test) in SKYLIGHT 1